Nocturnal blood pressure dipping as a marker of endothelial function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus
Authors:
Open Access
- 3 June 2020
- journal article
- research article
- Published by Springer Nature in Arthritis Research & Therapy
- Vol. 22 (1) , 1-10
Abstract
Background: Loss of the normal nocturnal decline in blood pressure (BP), known as non-dipping, is a potential measure of cardiovascular risk identified by ambulatory blood pressure monitoring (ABPM). We sought to determine whether non-dipping is a useful marker of abnormal vascular function and subclinical atherosclerosis in pediatric-onset systemic lupus erythematosus (pSLE). Methods: Twenty subjects 9–19 years of age with pSLE underwent ABPM, peripheral endothelial function testing, carotid-femoral pulse wave velocity/analysis for aortic stiffness, and carotid intima-media thickness. We assessed the prevalence of non-dipping and other ABPM abnormalities. Pearson or Spearman rank correlation tests were used to evaluate relationships between nocturnal BP dipping, BP load (% of abnormally elevated BPs over 24-h), and vascular outcome measures. Results: The majority (75%) of subjects had inactive disease, with mean disease duration of 3.2 years (± 2.1). The prevalence of non-dipping was 50%, which occurred even in the absence of nocturnal or daytime hypertension. Reduced diastolic BP dipping was associated with poorer endothelial function (r 0.5, p = 0.04). Intima-media thickness was significantly greater in subjects with non-dipping (mean standard deviation score of 3.0 vs 1.6, p = 0.02). In contrast, higher systolic and diastolic BP load were associated with increased aortic stiffness (ρ 0.6, p = 0.01 and ρ 0.7, p < 0.01, respectively), but not with endothelial function or intima-media thickness. Conclusion: In a pSLE cohort with low disease activity, isolated nocturnal BP non-dipping is prevalent and associated with endothelial dysfunction and atherosclerotic changes. In addition to hypertension assessment, ABPM has a promising role in risk stratification and understanding heterogeneous mechanisms of cardiovascular disease in pSLE.Keywords
All Related Versions
Funding Information
- Lupus Foundation of America
- National Center for Advancing Translational Sciences (UL1TR001878)
- National Heart, Lung, and Blood Institute (K01HL125521)
- Pulmonary Hypertension Association
This publication has 51 references indexed in Scilit:
- Carotid Artery Intima-Media Thickness and Distensibility in Children and AdolescentsHypertension, 2013
- Ambulatory blood pressure and subclinical cardiovascular disease in patients with juvenile-onset systemic lupus erythematosusPediatric Nephrology, 2012
- Importance of cumulative exposure to elevated cholesterol and blood pressure in development of atherosclerotic coronary artery disease in systemic lupus erythematosus: a prospective proof-of-concept cohort studyArthritis Research & Therapy, 2011
- Systemic lupus erythematosus and the risk of cardiovascular disease: Results from the nurses' health studyArthritis Care & Research, 2009
- Premature atherosclerosis in pediatric systemic lupus erythematosus: Risk factors for increased carotid intima‐media thickness in the atherosclerosis prevention in pediatric lupus erythematosus cohortArthritis & Rheumatism, 2009
- New Equations to Estimate GFR in Children with CKDJournal of the American Society of Nephrology, 2009
- Effects of Childhood Primary Hypertension on Carotid Intima Media ThicknessHypertension, 2006
- Assessment of peripheral vascular endothelial function with finger arterial pulse wave amplitudeAmerican Heart Journal, 2003
- Oscillometric twenty-four-hour ambulatory blood pressure values in healthy children and adolescents: A multicenter trial including 1141 subjectsThe Journal of Pediatrics, 1997
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992